{"podcast":{"title":"Perth News Today | 2 Min News | The Daily News Now!","slug":"perth-news-today-2-min-news-the-daily-news-now-7574199","podcast_index_feed_id":7574199,"rss_url":"https://feeds.fastcast.ai/new-york-liberty-the-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/new-york-liberty-the-daily-news-now.jpg","author":"The Daily News Now!","episode_count":1317,"summary":"Perth News Today is your daily two-minute briefing on everything happening in Perth and across Western Australia. Get fast, reliable updates on breaking local news, WA government decisions, crime and public safety, weather, traffic and transport, housing and real estate, business, jobs, mining and resources, and the local economy. Powered by AI and voiced by Corey with the Story, Perth News Today delivers clear, factual headlines designed for busy listeners who want to stay informed without the noise.New episodes publish daily with coverage from Perth CBD, Fremantle, Subiaco, Joondalup, Scarborough, and Greater Perth.Stay informed with Perth News Today, part of the global Daily News Now network.DNN | The Daily News Now!The world’s first global local news network.Every city. Every story. AI powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-23T14:19:38.707477+00:00","page_url":"https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199"},"episode":{"title":"Donanemab Shows Promise for Alzheimer's | Perth News","slug":"donanemab-shows-promise-for-alzheimer-s-perth-news","published_at":"2026-07-17T09:06:31+00:00","page_url":"https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199/donanemab-shows-promise-for-alzheimer-s-perth-news","show_page_url":"https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199","url":"https://sources.thednn.ai/faa36404c0f32c36","audio_url":"https://api.fastcast.ai/audio/4cbee219-6855-400f-a839-fefba0cd3a8c.mp3","summary":"A breakthrough Alzheimer’s drug called donanemab is showing real promise, slowing cognitive decline for up to three years in early-stage patients—some even after treatment ends. In a major study of 1,200 people, those receiving the IV drug saw significantly slower mental decline, with amyloid plaques slashed by 90% and tau markers reduced. But caution is needed: rare but serious side effects like brain swelling and bleeding have occurred, including deaths. Though licensed, it’s not yet on the NHS due to cost concerns, and widespread rollout faces systemic hurdles as dementia cases surge. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/faa36404c0f32c36","meta_description":"A breakthrough Alzheimer’s drug called donanemab is showing real promise, slowing cognitive decline for up to three years in early-stage patients—some eve…","key_points":[],"chapters":[],"topics":[],"duration_seconds":106,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/perth-news-today-2-min-news-the-daily-news-now-7574199/episodes/donanemab-shows-promise-for-alzheimer-s-perth-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199/donanemab-shows-promise-for-alzheimer-s-perth-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}